Bringing precision oncology to cellular resolution with single-cell genomics

被引:0
作者
Yuntao Xia
Charles Gawad
机构
[1] Stanford University,Department of Pediatrics, Division of Hematology/Oncology
来源
Clinical & Experimental Metastasis | 2022年 / 39卷
关键词
Single cell genomics; Precision oncology;
D O I
暂无
中图分类号
学科分类号
摘要
Single-cell sequencing technologies have undergone rapid development and adoption by the scientific community in the past 5 years, fueling discoveries about the etiology, pathogenesis, and treatment responsiveness of individual tumor cells within cancer ecosystems. Most of the advancements in our understanding of cancer with these new technologies have focused on basic tumor biology. However, the knowledge produced by these and other studies are beginning to provide biomarkers and drug targets for clinically-relevant subpopulations within a tumor, creating opportunities for the development of biologically-informed, clone-specific combination treatment strategies. Here we provide an overview of the development of the field of single-cell cancer sequencing and provide a roadmap for shepherding these technologies from research tools to diagnostic instruments that provide high-resolution, treatment-directing details of tumors to clinical oncologists.
引用
收藏
页码:79 / 83
页数:4
相关论文
共 57 条
[1]  
Lander ES(2001)Initial sequencing and analysis of the human genome Nature 409 860-921
[2]  
Tucker T(2009)Massively parallel sequencing: the next big thing in genetic medicine Am J Hum Genet 85 142-154
[3]  
Marra M(2020)Pan-cancer analysis of whole genomes Nature 578 82-93
[4]  
Friedman JM(2018)Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours Nature 555 371-376
[5]  
Consortium IT(2018)Association of broad-based genomic sequencing with survival among patients with advanced non-small cell lung cancer in the community oncology setting JAMA 320 469-477
[6]  
Ma X(2017)Deciphering genetic intratumor heterogeneity and its impact on cancer evolution Annu Rev Cancer Biol 1 223-240
[7]  
Presley CJ(2018)Tumour heterogeneity and resistance to cancer therapies Nat Rev Clin Oncol 15 81-94
[8]  
Rosenthal R(2021)Towards multi-omics characterization of tumor heterogeneity: a comprehensive review of statistical and machine learning approaches Brief Bioinform 22 bbaa188-e416
[9]  
Dagogo-Jack I(2019)Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas Gut 50 e416-272
[10]  
Shaw AT(2018)The significance of intertumor and intratumor heterogeneity in liver cancer Exp Mol Med 20 257-188